<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/53A8F4B4-EBD0-4199-B24B-B5008112311D"><gtr:id>53A8F4B4-EBD0-4199-B24B-B5008112311D</gtr:id><gtr:name>Guy's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8BFE03FB-6AF2-46C4-942E-1262EFD09774"><gtr:id>8BFE03FB-6AF2-46C4-942E-1262EFD09774</gtr:id><gtr:name>Royal Free London NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Pond Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW3 2QG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BC5360A4-17EF-4970-9A81-98DFBA9EFF84"><gtr:id>BC5360A4-17EF-4970-9A81-98DFBA9EFF84</gtr:id><gtr:name>Great Ormond Street Hospital Children's Charity (GOSHCC)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/53A8F4B4-EBD0-4199-B24B-B5008112311D"><gtr:id>53A8F4B4-EBD0-4199-B24B-B5008112311D</gtr:id><gtr:name>Guy's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8BFE03FB-6AF2-46C4-942E-1262EFD09774"><gtr:id>8BFE03FB-6AF2-46C4-942E-1262EFD09774</gtr:id><gtr:name>Royal Free London NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Pond Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW3 2QG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BC5360A4-17EF-4970-9A81-98DFBA9EFF84"><gtr:id>BC5360A4-17EF-4970-9A81-98DFBA9EFF84</gtr:id><gtr:name>Great Ormond Street Hospital Children's Charity (GOSHCC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/47A52A1C-9020-4F51-9010-5015BF9BE703"><gtr:id>47A52A1C-9020-4F51-9010-5015BF9BE703</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:surname>Logan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_13052"><gtr:id>662F0AAB-8C54-4FE5-B018-1E7D21BEE5FB</gtr:id><gtr:title>Vertebrate Limb Development 2</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_13052</gtr:grantReference><gtr:abstractText>Abnormalities in normal heart formation are the most common birth defect, occurring in 1 in 120 live births. If uncorrected, these defects can have serious debilitating effects on quality of life and in severe cases lead to premature death. Other less life-threatening birth defects also dramatically decrease quality of life in affected individuals. Among these, limb defects are the most common. We are interested in studying the causes of two human syndromes that lead to serious abnormalities in normal heart and limb formation. Patients with Holt-Oram Syndrome (HOS) have severely malformed hearts and limbs and those with Ulnar-Mammary Syndrome (UMS) are afflicted with abnormal limb and mammary gland development.|In each syndrome the corruption of the genetic information in a single gene is sufficient to cause all of the associated abnormalities. Armed with this knowledge of the exact genetic cause of each syndrome we propose to investigate the underlying biology of these diseases. Using the mouse and chicken, we are generating syndrome models that provide a powerful method to understand how loss of normal gene function leads to the disruption of heart and limb formation. In both animal models, the development of the heart and limbs occurs in a similar manner to our own and each animal model has experimental advantages we can exploit. Understanding the genesis of these syndromes will provide information vital in order to devise more effective diagnostic and corrective treatments in human patients.</gtr:abstractText><gtr:technicalSummary>Limb defects are the second most common congenital abnormality present in human live births and diseases affecting the musculoskeletal system are a significant clinical problem, particularly in the older population. The goal of our work is to understand how the limbs form normally during embryogenesis and the genesis of limb abnormalities and diseases that affect the musculoskeletal system in humans. ||Limbs are formed from specific regions of the flank of the embryo. At early stages of embryonic development, the forelimb and hindlimb buds are morphologically uniform and indistinguishable from one another. During subsequent steps of development however, dramatic changes take place. Each bud develops to form a network of interconnected limb elements e.g. bones, muscles, and tendons-with morphologies characteristic of either the forelimb or hindlimb. We are using vertebrate animal models to understand the mechanisms that control the initiation of limb bud formation and the subsequent construction of the individual limb elements during embryonic development. A longer-term aim is to apply these findings to develop to potential therapeutic approaches that could contribute to maintenance and possible regeneration of these structures in later life.||We use the developing limb as a model system using predominantly mouse and chick model organisms but also zebrafish and frog (and in future, as part of collaboration, we also plan to include Bat). In general our strategy is to interrogate gene function using a combination of coordinated gene misexpression and gene deletion experiments, often in more than one model system. In the mouse, we take advantage of gene conditional alleles and a repertoire of Cre deleter transgenics that we have developed ourselves or have collected. We often include transgene reporters to aid in phenotyping. In the chick, we are using genetic techniques to misexpress genes (either retroviral vectors or electroporation or direct application of recombinant proteins or substances) in combination with more classical embryological approaches. A new and important aspect of current and future work is to develop the use of in vitro techniques as an alternative, complementary approach to our in vivo models. Currently this involves the generation and characterisation of cell lines derived from transgenic reporter mouse lines we have produced and collected.</gtr:technicalSummary><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>951068</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Tamsin is a ceramicist-http://www.vanessendesign.com/- who is developing works based on interaction with the lab over the next 6 months</gtr:description><gtr:id>0A3DE5FA-5F6A-4B6D-A4AB-D55DC4B6B323</gtr:id><gtr:impact>work in progress</gtr:impact><gtr:outcomeId>5460cb4cacf510.42644408</gtr:outcomeId><gtr:title>Collaboration with Tamsin van Essen</gtr:title><gtr:type>Artwork</gtr:type><gtr:url>http://www.vanessendesign.com/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>We collaborated with artist Paddy to help him develop his biosculpture project &amp;quot;Papaver rhoeas&amp;quot; http://paddyhartley.com/papaver-rhoeas-2/
These series of exhibits encourage reflection on the meaning and use of remembrance, drawing particularly on the use and symbolism of the poppy in commemorating wars and war dead. This resulted in several exhibitions at the end of 2015 and further exhibitions are scheduled for 2016.
http://paddyhartley.com/</gtr:description><gtr:id>150401FF-047B-4B14-A2A1-092E92B65BB0</gtr:id><gtr:impact>several exhibitions at the end of 2015 and further exhibitions are scheduled for 2016.
http://paddyhartley.com/</gtr:impact><gtr:outcomeId>56cb8db69aec34.96173849</gtr:outcomeId><gtr:title>Collaboration with artist Paddy Hartley</gtr:title><gtr:type>Artwork</gtr:type><gtr:url>http://paddyhartley.com/papaver-rhoeas-2/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Using a Prx1 transgenic to study the periosteal stem cell niche</gtr:description><gtr:id>37AA5092-5559-4FCD-AD04-5D6D2FE47AD4</gtr:id><gtr:impact>BBSRC-CASE studnetship awarded to a PhD student who I am hositng in my lab but who will also work directly with teams at UCB</gtr:impact><gtr:outcomeId>58c5c307b3dd70.83323876-1</gtr:outcomeId><gtr:partnerContribution>Experise in bone biology, techniaues in bone biology and novel reagents for studying bone biology (particularly immuno therapy reagents and osteogenic bone matrices).
A biopharma outlook on a biological and clinical probelm.</gtr:partnerContribution><gtr:piContribution>My lab is contributing a unique reagent that we produced that enables a cell-type of interest in bone to be studied and isolated.
My lab contributes expertise in embryogensis, genetic tools and genetic approaches and imaging analysis</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free London NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with plastics and reconstructive surgeons</gtr:description><gtr:id>75553AEB-1C92-4026-AEF0-BF5B19034977</gtr:id><gtr:impact>Mres project completed and succesful production of preliminary data. plans for further work</gtr:impact><gtr:outcomeId>5461e675589039.25287035-2</gtr:outcomeId><gtr:partnerContribution>Developing ongoing collaborative work to explore ways to improved surgical approaches and surgical outcomes in limb reconstructive surgery</gtr:partnerContribution><gtr:piContribution>Hosting and collaborating with ploastic surgeons with specialities in reconstructive surgery of hand
Mr Branivan Sivakumar
Miss Gill Smith
Dr George Murphy
Dr Log Murugesan</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's and St Thomas' NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Quantifying the effects of treatments to reduce immunogenicity of tendon xeno/allografts</gtr:description><gtr:id>69D4DDD1-85CF-4636-A298-D0A60927583D</gtr:id><gtr:impact>work ongoing. Follwoing results of pilot will (i) publish study in clinical journal (ii) explore possibiklity to extend collaboration and seek funding for further work</gtr:impact><gtr:outcomeId>58c5c4ae3cb6f2.27182005-1</gtr:outcomeId><gtr:partnerContribution>Provide clinical link for study and samples for analysis</gtr:partnerContribution><gtr:piContribution>Initiating a pilot study with a collaborator, Mr Adil Adjued, Consultant orthopaedic surgeon, GSST to quantify the effects of treatments to reduce immune response/rejevtion of tendon xeno or allografts for surgical replacement following tendon injury/failure.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DECIPHER/DDD Radial Ray Defects^60 Holder-Espinasse</gtr:description><gtr:id>A3F6C48F-FBA0-4334-8151-44993B5D95C1</gtr:id><gtr:impact>only established in 2014</gtr:impact><gtr:outcomeId>5460a1b035d6e6.96881217-1</gtr:outcomeId><gtr:partnerContribution>Provide the clinical lead in partnership and have direct access/contact with patients</gtr:partnerContribution><gtr:piContribution>I have actively search for and established links with clinicians interested in limb defects. We have developed a strategy to identify patients/families for further study and the key goals for the short and medium term to best deliver impacst on improved patient care and to develop knowledge of the causes and treatments of limb defects</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital Children's Charity (GOSHCC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with plastics and reconstructive surgeons</gtr:description><gtr:id>70E10AD5-D949-4F82-A8DA-06A7ACAD76F5</gtr:id><gtr:impact>Mres project completed and succesful production of preliminary data. plans for further work</gtr:impact><gtr:outcomeId>5461e675589039.25287035-1</gtr:outcomeId><gtr:partnerContribution>Developing ongoing collaborative work to explore ways to improved surgical approaches and surgical outcomes in limb reconstructive surgery</gtr:partnerContribution><gtr:piContribution>Hosting and collaborating with ploastic surgeons with specialities in reconstructive surgery of hand
Mr Branivan Sivakumar
Miss Gill Smith
Dr George Murphy
Dr Log Murugesan</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Contribution to National Gallery activity packs</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9F08EB68-7F83-450A-855A-97CCCB80F0E2</gtr:id><gtr:impact>Invited to contribute to development of the National Gallery's children's activity packs. In particular scientific advice on development of ideas of encourage children to look at paintings in different ways and see the science under the paintings</gtr:impact><gtr:outcomeId>56cb902e331e66.89536832</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gave talk for &quot;Pint of Science&quot; festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3B90ADC3-2859-4FD4-9B85-E79556B59F1B</gtr:id><gtr:impact>Gave a talk (alongside a clinical collaborator, Bran Sivakumar) to general public describing the work we do to study the rogins of limb defects and improving clinical treatments</gtr:impact><gtr:outcomeId>58c5c9d1ea8d95.85881801</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.co.uk/event/building-body-parts</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genetics Society executive committee member</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EEC389DD-6CCB-47EA-84D9-09C6437E7972</gtr:id><gtr:impact>genetics Society committee meetings
Genetics Society Executive meetings
Interview panels for genetics Society
Working group for Centenary celebrations
Dealing with Genetics Society journals (Heredity and Genes and Development) Liason with publihsers Springer-Nature and CSHP


genetics Society committee meeting</gtr:impact><gtr:outcomeId>d9gdvG9w6qv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.genetics.org.uk/</gtr:url><gtr:year>2013,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advice to author David Nicholls</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60FC54F2-FEFC-47D7-8A8E-E96A296C7D4C</gtr:id><gtr:impact>provided advice to author preparing a novel with main protagonist a scientist

giving advice to author with very large audience to help produce a pro-science book that humanises the practice of science and demsytifies science and scientists to the general public</gtr:impact><gtr:outcomeId>5460c8408fd939.39856306</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.davidnichollswriter.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation for Thalidomide Trust UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>18885FFA-0E76-4A3B-A96F-D63C08F98A3F</gtr:id><gtr:impact>open new avenues for interactions
Talk stimulated debate and future activities

After the talk I was asked to provide advice to former chairman of Trust who is writing a book on origins of Thalidomide
Also met potential collaborators for future work on Thalidomide causes and treatment</gtr:impact><gtr:outcomeId>5460c70b3d4917.24203691</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.thalidomidetrust.org/public/national-advisory-council-nac/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advice to Author Helen Pilcher for her book &quot;Bring back the King-The science of de-extinction&quot;</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32D0406A-83E6-4F95-8719-7168F0051D7C</gtr:id><gtr:impact>Gave advice to author Helen Pilcher as she was preparing her book</gtr:impact><gtr:outcomeId>58c5cb724a3e61.42817847</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bloomsbury.com/author/helen-pilcher</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contribution to WHO meeting on Thalidomide embryopathy</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>84EC33F6-26F7-4868-A9D9-9AE427EC2A7E</gtr:id><gtr:impact>WHO report published
 http://www.thalidomidetrust.org/thalidomide-embryopathy-world-health-organisation-report/

After my contribution I estyablihsed new links with workers/policy makers on Thalidomide embryopathy
I have since given a presentation for the Thalidomide trust, been invited to write a report for Thalidomide trust and have established a collaboration with a Japanese group working on Thalidomide embryopathy</gtr:impact><gtr:outcomeId>5460b675d26197.35906274</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>122104</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC-CASE Studentship 4yr</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>UCB Pharma</gtr:fundingOrg><gtr:id>F17F9C7E-5B59-4475-8BDB-5B68A1441FE0</gtr:id><gtr:outcomeId>58bd83f1de0c24.61145317</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship funding for clinical fellow (speciality in plastic surgery of limbs) in lab</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Society for Surgery of the Hand (BSSH)</gtr:fundingOrg><gtr:id>538F9F76-8D60-47C8-B885-C750C6C5348E</gtr:id><gtr:outcomeId>58c5d03a2ebe64.44204018</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to WHO meeting on causes of Thalidomide Embryopathy</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>DE231809-EB12-4AD3-9EC9-A56ABC8A5472</gtr:id><gtr:outcomeId>5460c941296889.78896526</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type><gtr:url>http://www.thalidomidetrust.org/thalidomide-embryopathy-world-health-organisation-report/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Education Policy Advisory Panel (EPAG) for Gen Soc as part of Society of Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7AED3A43-B38D-4D0F-B55B-F8A311AA2C2A</gtr:id><gtr:outcomeId>5460b430a5e248.89488520</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.societyofbiology.org/education</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Vice president corporate affairs, Genetics Society</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>14827263-436F-4292-842F-D6AC7B5B7C93</gtr:id><gtr:outcomeId>5461e8863a3194.18374834</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Prx1Cre and Prx1CreERt2 transgenic mouse lines</gtr:description><gtr:id>3EA41737-7BC8-4B9E-8040-D5E23FBA831D</gtr:id><gtr:impact>Continually requested research tools that are finding new uses for a broader range of studies including cancer studies
Continually cited in published work</gtr:impact><gtr:outcomeId>58c5cde91c44b7.90702088</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Prx1Cre and Prx1CreERt2 transgenic mouse lines</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An interactive 3D anatomy atlas of the embryonic mouse forelimb and hindlimb</gtr:description><gtr:id>4A6D7B97-15C3-4126-A819-619D7C5B1C80</gtr:id><gtr:impact>Improved Anatomy atlas that is more user-friendly and more stable across multiple platforms
I get enquiries about the database
The database is cited in publications</gtr:impact><gtr:outcomeId>58c5cd20d46919.67107150</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>3D Mouse Limb anatomy database</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>https://www.emouseatlas.org/emap/ema/modelsummary/modelsummary.html</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C3D33A40-BD27-4B4B-80C4-64CBAE26FDE1</gtr:id><gtr:title>A combination of activation and repression by a colinear Hox code controls forelimb-restricted expression of Tbx5 and reveals Hox protein specificity.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50b6c0fc2bdceafdbc7cd2da149f9854"><gtr:id>50b6c0fc2bdceafdbc7cd2da149f9854</gtr:id><gtr:otherNames>Nishimoto S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>545cede5e84436.53820167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1973C0B-BB1A-4394-951D-8056590E2BD7</gtr:id><gtr:title>Pitx1 determines characteristic hindlimb morphologies in cartilage micromass culture.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4260775c9021ff0c016e94e912981ab"><gtr:id>b4260775c9021ff0c016e94e912981ab</gtr:id><gtr:otherNames>Butterfield NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fd5aa4bdb50.96286503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BE3608B-E12E-4A43-8E72-CB5645CD9BEB</gtr:id><gtr:title>Regulatory modulation of the T-box gene Tbx5 links development, evolution, and adaptation of the sternum.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/416aa0932b3ca50398b993a60c9a83c2"><gtr:id>416aa0932b3ca50398b993a60c9a83c2</gtr:id><gtr:otherNames>Bickley SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546337cf94b5b2.34219507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A373F8CB-B3E8-406A-9941-45C6B925D87A</gtr:id><gtr:title>The Roles of T-Box Genes in Vertebrate Limb Development.</gtr:title><gtr:parentPublicationTitle>Current topics in developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b69a048819db75982693bca21e15ef0"><gtr:id>7b69a048819db75982693bca21e15ef0</gtr:id><gtr:otherNames>Sheeba CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0070-2153</gtr:issn><gtr:outcomeId>58bd7fee69c8f7.52723429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A512781-5A5D-41E2-A691-C1AC25ADF97F</gtr:id><gtr:title>Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e115f7dbb9496abcf9c36354e92dbfd"><gtr:id>7e115f7dbb9496abcf9c36354e92dbfd</gtr:id><gtr:otherNames>Javaheri T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd7fee9a1d44.91118052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1B6FCC1-47D2-489E-8C49-40AF94AD8C46</gtr:id><gtr:title>Correction of &amp;quot;Wrist&amp;quot; Deformity in Radial Dysplasia: A Systematic Review and Meta-Analysis.</gtr:title><gtr:parentPublicationTitle>The Journal of bone and joint surgery. American volume</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f09a6027b456abab3b6e6906edce8e8b"><gtr:id>f09a6027b456abab3b6e6906edce8e8b</gtr:id><gtr:otherNames>Murphy GRF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9355</gtr:issn><gtr:outcomeId>5a93f2c72fb7d5.76212507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC06CF29-4C3C-4F84-BAA5-1EA6A580682B</gtr:id><gtr:title>Tbx5 Buffers Inherent Left/Right Asymmetry Ensuring Symmetric Forelimb Formation.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd6f921fccd8494427a7c0387055b2e2"><gtr:id>cd6f921fccd8494427a7c0387055b2e2</gtr:id><gtr:otherNames>Sulaiman FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>58bd7feecc2856.70681117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A563300A-63D7-48C7-B473-FB35B00EF788</gtr:id><gtr:title>Application of Impermeable Barriers Combined with Candidate Factor Soaked Beads to Study Inductive Signals in the Chick.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e95143275de277e7257d4b5bbcb3126"><gtr:id>3e95143275de277e7257d4b5bbcb3126</gtr:id><gtr:otherNames>Wilde S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>58bd7fee368a87.95650835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E87144F-AC6D-477D-93AE-86D758806D25</gtr:id><gtr:title>Subdivision of the lateral plate mesoderm and specification of the forelimb and hindlimb forming domains.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50b6c0fc2bdceafdbc7cd2da149f9854"><gtr:id>50b6c0fc2bdceafdbc7cd2da149f9854</gtr:id><gtr:otherNames>Nishimoto S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>56cb8826019300.88791658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DF80601-1ADA-4202-AE7A-B707ECDE12F3</gtr:id><gtr:title>Bat Accelerated Regions Identify a Bat Forelimb Specific Enhancer in the HoxD Locus.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b549b094a7c368a2c0cd2f27ea56d9b8"><gtr:id>b549b094a7c368a2c0cd2f27ea56d9b8</gtr:id><gtr:otherNames>Booker BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>58bd7fedf0e2a3.41367772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA1552CE-397E-4F3F-8D0D-87109D6D2686</gtr:id><gtr:title>RA Acts in a Coherent Feed-Forward Mechanism with Tbx5 to Control Limb Bud Induction and Initiation.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50b6c0fc2bdceafdbc7cd2da149f9854"><gtr:id>50b6c0fc2bdceafdbc7cd2da149f9854</gtr:id><gtr:otherNames>Nishimoto S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5675e9590322c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB91D6D1-F753-4AB0-B2E5-B223926D6FE2</gtr:id><gtr:title>Retinoic acid-independent expression of Meis2 during autopod patterning in the developing bat and mouse limb.</gtr:title><gtr:parentPublicationTitle>EvoDevo</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df79c14551d552c79b45df3a9a2b8600"><gtr:id>df79c14551d552c79b45df3a9a2b8600</gtr:id><gtr:otherNames>Mason MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-9139</gtr:issn><gtr:outcomeId>56cb88c7ea8499.26572440</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_13052</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>